Business case
Our client, a world-leading cosmetics group, was considering a minority investment in a Swiss biotechnology company that had developed an innovative molecule in the longevity segment, with applications in the cosmetics and nutritional segments.
The longevity segment in the cosmetic industry is rapidly gaining traction, driven by growing consumer interest in anti-ageing, preventative care and scientifically backed wellness solutions that promise not just aesthetic improvement but extended youthfulness and vitality.
We performed the financial and strategic due diligence on the target, and we also reviewed its business plan to assess its future viability.